Adial Pharmaceuticals Stock Price on October 18, 2024
| ADIL Stock | USD 1.09 0.01 0.91% |
Below is the normalized historical share price chart for Adial Pharmaceuticals extending back to July 27, 2018. This chart has been adjusted for all splits and dividends and is plotted against all major global economic recessions. As of today, the current price of Adial Pharmaceuticals stands at 1.09, as last reported on the 17th of December 2024, with the highest price reaching 1.09 and the lowest price hitting 1.06 during the day.
If you're considering investing in Adial Stock, it is important to understand the factors that can impact its price. As of now, Adial Stock is moderately volatile. Adial Pharmaceuticals secures Sharpe Ratio (or Efficiency) of 0.023, which signifies that the company had a 0.023% return per unit of risk over the last 3 months. We have found twenty-nine technical indicators for Adial Pharmaceuticals, which you can use to evaluate the volatility of the firm. Please confirm Adial Pharmaceuticals' Risk Adjusted Performance of 0.0218, mean deviation of 2.66, and Downside Deviation of 3.56 to double-check if the risk estimate we provide is consistent with the expected return of 0.0923%.
At this time, Adial Pharmaceuticals' Common Stock Shares Outstanding is quite stable compared to the past year. Stock Based Compensation is expected to rise to about 2.3 M this year, although the value of Total Stockholder Equity will most likely fall to about 3.1 M. . At this time, Adial Pharmaceuticals' Price Book Value Ratio is quite stable compared to the past year. Price To Book Ratio is expected to rise to 0.68 this year, although the value of Price Earnings To Growth Ratio will most likely fall to 0.01. Adial Stock price history is provided at the adjusted basis, taking into account all of the recent filings.
IPO Date 30th of July 2018 | 200 Day MA 1.2748 | 50 Day MA 1.0414 | Beta 1.296 |
Adial |
Sharpe Ratio = 0.023
| Best Portfolio | Best Equity | |||
| Good Returns | ||||
| Average Returns | ||||
| Small Returns | ||||
| Cash | Small Risk | Average Risk | ADIL | Huge Risk |
| Negative Returns |
Estimated Market Risk
| 4.02 actual daily | 35 65% of assets are more volatile |
Expected Return
| 0.09 actual daily | 1 99% of assets have higher returns |
Risk-Adjusted Return
| 0.02 actual daily | 1 99% of assets perform better |
Based on monthly moving average Adial Pharmaceuticals is performing at about 1% of its full potential. If added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Adial Pharmaceuticals by adding it to a well-diversified portfolio.
Price Book 1.1922 | Book Value 2.455 | Enterprise Value 4.9 M | Enterprise Value Ebitda (0.49) | Shares Float 6.3 M |
Related Headline
Emergent Biosolutions Headline on 18th of October 2024
Acquisition by Ronald Richard of 33847 shares of Emergent Bi... by Ronald Richard
Filed transaction by Emergent Biosolutions Director. Grant, award or other acquisition pursuant to Rule 16b-3
Adial Pharmaceuticals Valuation on October 18, 2024
It is possible to determine the worth of Adial Pharmaceuticals on a given historical date. On October 18, 2024 Adial was worth 0.98 at the beginning of the trading date compared to the closed value of 1.01. We use multiple weighted factors in our valuation methodologies to arrive at the intrinsic value of Adial Pharmaceuticals stock. Still, in general, we apply an absolute valuation method to find Adial Pharmaceuticals' value based on its fundamental and technical indicators available within our service. As compared to an absolute model, our relative valuation model uses a comparative analysis of Adial Pharmaceuticals where we calculate exposure to its market risk and evaluate relevant financial multiples and ratios against Adial Pharmaceuticals' related companies.
| Open | High | Low | Close | Volume | |
| 1.04 | 1.04 | 0.95 | 0.97 | 324,204 | |
10/18/2024 | 0.98 | 1.05 | 0.97 | 1.01 | 240,123 |
| 1.04 | 1.10 | 1.03 | 1.07 | 297,521 |
| Backtest Adial Pharmaceuticals | | | Adial Pharmaceuticals History | | | Adial Pharmaceuticals Valuation | Previous | Next |
Adial Pharmaceuticals Trading Date Momentum on October 18, 2024
| On October 21 2024 Adial Pharmaceuticals was traded for 1.07 at the closing time. The top price for the day was 1.10 and the lowest listed price was 1.03 . The trading volume for the day was 297.5 K. The trading history from October 21, 2024 was a factor to the next trading day price upswing. The overall trading delta against the next closing price was 5.94% . The overall trading delta against the current closing price is 7.92% . |
Adial Pharmaceuticals Fundamentals Correlations and Trends
By evaluating Adial Pharmaceuticals' financials over time, investors can gain insight into future company performance. However, you can also analyze the published financial statements to find patterns among Adial Pharmaceuticals' main balance sheet or income statement drivers and many other relevant indicators that can statistically be found significantly correlated or uncorrelated. Adial financial account trend analysis is a perfect complement when working with valuation or volatility modules.About Adial Pharmaceuticals Stock history
Adial Pharmaceuticals investors dedicate a lot of time and effort to gaining insight into how a market's past behavior relates to its future. Access to timely market data for Adial is vital when making an investment decision, and regardless of whether you use fundamental or technical analysis, your return on investment in Adial Pharmaceuticals will depend on recognizing future opportunities and eliminating past mistakes. Historical data analysis is the study of market behavior over a given time. Recorded market-related data such as price, volatility, and volume can be quantified and studied over a defined period. Through a detailed examination of a market's past behavior, traders and investors can gain perspective on the inner workings of that market. The information obtained throughout analyzing Adial Pharmaceuticals stock prices may prove useful in developing a viable investing in Adial Pharmaceuticals
| Last Reported | Projected for Next Year | ||
| Common Stock Shares Outstanding | 1.4 M | 1.5 M | |
| Net Loss | -17.5 M | -16.6 M |
Adial Pharmaceuticals Quarterly Net Working Capital |
|
Adial Pharmaceuticals Stock Technical Analysis
Adial Pharmaceuticals technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.
Price Boundaries
Adial Pharmaceuticals Period Price Range
Low | December 17, 2024
| High |
0.00 | 0.00 |
Adial Pharmaceuticals cannot be verified against its exchange. Please verify the symbol is currently traded on NASDAQ Exchange. If you still believe the symbol you are trying to look up is valid, please let us know, and we will check it as soon as possible.
Adial Pharmaceuticals December 17, 2024 Market Strength
Market strength indicators help investors to evaluate how Adial Pharmaceuticals stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading Adial Pharmaceuticals shares will generate the highest return on investment. By undertsting and applying Adial Pharmaceuticals stock market strength indicators, traders can identify Adial Pharmaceuticals entry and exit signals to maximize returns
Adial Pharmaceuticals Technical and Predictive Indicators
Predictive indicators are helping investors to find signals for Adial Pharmaceuticals' price direction in advance. Along with the technical and fundamental analysis of Adial Stock historical price patterns, it is also worthwhile for investors to track various predictive indicators of Adial to make sure they correctly time the market and exploit it's hidden potentials. Even though most predictive indicators are useful for the short-term horizon, it's virtually impossible to predict the unforeseen market. For traders with a short-term horizon, predictive indicators add value when properly applied. Long-term investors, however, may find many predictive indicators less useful.
| Risk Adjusted Performance | 0.0218 | |||
| Jensen Alpha | 0.092 | |||
| Total Risk Alpha | (0.35) | |||
| Sortino Ratio | (0) | |||
| Treynor Ratio | (0.18) |
| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Adial Pharmaceuticals. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in gross domestic product. For more information on how to buy Adial Stock please use our How to buy in Adial Stock guide.You can also try the Insider Screener module to find insiders across different sectors to evaluate their impact on performance.
Is Pharmaceuticals space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Adial Pharmaceuticals. If investors know Adial will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Adial Pharmaceuticals listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (2.94) | Return On Assets (1.04) | Return On Equity (3.21) |
The market value of Adial Pharmaceuticals is measured differently than its book value, which is the value of Adial that is recorded on the company's balance sheet. Investors also form their own opinion of Adial Pharmaceuticals' value that differs from its market value or its book value, called intrinsic value, which is Adial Pharmaceuticals' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Adial Pharmaceuticals' market value can be influenced by many factors that don't directly affect Adial Pharmaceuticals' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Adial Pharmaceuticals' value and its price as these two are different measures arrived at by different means. Investors typically determine if Adial Pharmaceuticals is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Adial Pharmaceuticals' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.